Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-20T09:28:20.101Z Has data issue: false hasContentIssue false
  • English
  • Français

Abuses and Apologies: Irresponsible Conduct of Human Subjects Research in Latin America

Published online by Cambridge University Press:  01 January 2021

Julie M. Aultman
Get access Rights & Permissions [Opens in a new window]

Extract

As much as we can be squeamish and angry over what was being done in these studies, they force us to consider how we tell these stories and the policy we make now, as so much of our research is global and the risks and benefits of experimentation always in need of recalibration.

Susan M. Reverby

A growing distrust exists among Latin American populations as past abuses in medical research have rightly been publicized, and as researchers continue to intentionally and unintentionally circumvent the systems of regulation and oversight. Beyond the cultural gaps between researcher and subject, the Latin American people have their own perspectives about responsible conduct of research formed by sociopolitical thought and familial and community identity, which may be overlooked or ignored by the U.S. and other foreign nations. Just as the Havasupai Tribe in Arizona have challenged us to think about the role of culture and the need for improved regulations and practices in conducting research within the United States, through past abuses in human experimentation and the emergence of discourse between our Latin American neighbors, similar challenges confront us.

Type
Independent
Information
Journal of Law, Medicine & Ethics , Volume 41 , Issue 1 , Spring 2013 , pp. 353 - 368
Copyright
Copyright © American Society of Law, Medicine and Ethics 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Reverby, S. M., “‘Normal Exposure” and Inoculation Syphilis: A PHS “Tuskegee” Doctor in Guatemala, 1946–1948,” Journal of Policy History 23, no. 1 (2011): 6–28, at 22.Google Scholar
Latin America in this context includes all of the Americas south of the United States, including English-speaking countries, e.g., Belize, and French-speaking countries, e.g., French Guiana.Google Scholar
Luna, F., Bioethics and Vulnerability: A Latin American View (Amsterdam: Rodolpi, 2006): at 16.Google Scholar
Kaiser, J., “Panel Blasts Ethics, Science of 1940s Guatemala Studies,” Science 333, no. 6047 (2011): 1211.Google Scholar
The Lancet editorial staff, “Ethical Behavior in Clinical Research – A Lesson from the Past,” The Lancet 378, 9795 (2011): 962.Google Scholar
Id.Google Scholar
The President's Commission for the Study of Bioethical Issues, Executive Summary Report, “Research across Borders: Proceedings of the International Research Panel of the Presidential Commission for the Study of Bioethical Issues,” 2011, available at <http://bioethics.gov/cms/sites/default/files/IRP-Proceedings%20and%20Recommendations_0.pdf> (last visited February 27, 2013). (last visited February 27, 2013).' href=https://scholar.google.com/scholar?q=The+President's+Commission+for+the+Study+of+Bioethical+Issues,+Executive+Summary+Report,+“Research+across+Borders:+Proceedings+of+the+International+Research+Panel+of+the+Presidential+Commission+for+the+Study+of+Bioethical+Issues,”+2011,+available+at++(last+visited+February+27,+2013).>Google Scholar
DeYoung, K. and Nelson, D., “Latin America Is Ripe for Trials and Fraud,” Washington Post, December 21, 2000, available at <http://www.washingtonpost.com/ac2/wp-dyn/A31027-2000Dec20> (last visited January 1, 2012).+(last+visited+January+1,+2012).>Google Scholar
Weyzig, F. and Schipper, I., SOMO in collaboration with Wemos Foundation, briefing paper on ethics in clinical trials, “Examples of Unethical Trials,” February 2008, 1–16.Google Scholar
Lavery, J. V. Grady, C. Wahl, E. R., and Emanuel, E. J., Ethical Issues in International Biomedical Research: A Casebook (New York: Oxford University Press, 2007).Google Scholar
McCarthy, M., “US Company's Plan for Trial in Latin America Draws Fire,” The Lancet 357, no. 9257 (2001): 691.CrossRefGoogle Scholar
See McCarthy, , supra note 11, at 691.Google Scholar
See Weyzig, and Schipper, , supra note 9, at 9.Google Scholar
Leighton, P., “Study on Infants in Peru Sparks Controversy,” July, 18, 2006, available at <www.scidev.net/content/news/eng/study-on-infants-in-peru-sparks-ethics-inquiry.cfm> (last visited February 28, 2013).+(last+visited+February+28,+2013).>Google Scholar
Hearn, K., “The Rise of Unregulated Drug Trials in South America,” The Nation, September 21, 2011, available at <http://www.thenation.com/print/article/163547/rise-unregulated-drug-trials-south-america> (last visited February 28, 2013).+(last+visited+February+28,+2013).>Google Scholar
Evans, D. Smith, M., and Willen, L., “Big Pharma's Shameful Secret,” December 2005, available at <http://www.journalism.columbia.edu/system/documents/523/original/2006_Evans_Big_Pharma_s_Shameful_Secret_MAG.pdf> (last visited February 28, 2013). (last visited February 28, 2013).' href=https://scholar.google.com/scholar?q=Evans,+D.+Smith,+M.,+and+Willen,+L.,+“Big+Pharma's+Shameful+Secret,”+December+2005,+available+at++(last+visited+February+28,+2013).>Google Scholar
See Weyzig, and Schipper, , supra note 9, at 7.Google Scholar
See Evans, Smith, , and Willen, , supra note 16; Weyzig, and Schipper, , supra note 9, at 7.Google Scholar
Barnes, K., “Troubled SFBC Changes Its Name in Hope of Changing Its Fortunes,” Outsourcing Pharma.com, August 31, 2006, available at <http://www.outsourcing-pharma.com/Clinical-Development/Troubled-SFBC-changes-its-name-in-hope-of-changing-its-fortunes> (last visited February 28, 2013).+(last+visited+February+28,+2013).>Google Scholar
Takahashi, M. T. Ramos, H. F. Pinheiro-Neto, C. D. Miziara, I. D., and de Oliveira, Ayer R., “Current Outlook of Ethics in Research with Human Subjects,” Brazilian Journal of Otorhinolaryngology 77, no. 2 (2011): 263–266.Google Scholar
Ribeiro, C. R. O. and Zoboli, E. L. C. P., “Poverty, Bioethics and Research,” Revista of Latino-American Enfermagem 15, Spec No (2007): 843–849, at 847.CrossRefGoogle Scholar
See Ribeiro, and Zoboli, , supra 20, at 847.Google Scholar
See Luna, , supra 3, at 143.Google Scholar
O'Neill, O., Towards Justice and Virtue (Cambridge: Cambridge University Press, 1996); Ruof, M. C., “Vulnerability, Vulnerable Populations, and Policy,” Kennedy Institute of Ethics Journal 14, no. 4 (2004): 411–425, available at <http://bioethics.georgetown.edu/publications/scopenotes/sn44.pdf> (last visited February 28, 2013).Google Scholar
Hurst, S. A., “Vulnerability in Research and Health Care; Describing the Elephant in the Room?” Bioethics 22, no. 4 (2008): 191–202.CrossRefGoogle Scholar
Id., at 195.Google Scholar
Id.Google Scholar
Id., at 196.Google Scholar
Id., at 202 [Note: Hurst explains that her definition of vulnerability “does not address differences in the way that people may have become vulnerable. As has been proposed, differences between vulnerabilities that originate in injustice, or misfortune, or that are the fault of the vulnerable person herself, could well be relevant. According to the view proposed here, however, this would affect the legitimacy of the claim being considered, rather than the definition of vulnerability itself.” However, I argue that differences among people can be significant for understanding the variability of wrongs and the “layers” of vulnerability present, and can strengthen the legitimacy of the claims being considered.].Google Scholar
Garrafa, V. Solbakk, J. H. Vidal, S., and Lorenzo, C., “Between the Needy and the Greedy: The Quest for a Just and Fair Ethics of Clinical Research,” Journal of Medical Ethics 36, no. 8 (2010): 500–504, at 501. See Garrafa, Solbakk, Vidal, , and Lorenzo, , supra 30, at 502.CrossRefGoogle Scholar
Id., at 502.Google Scholar
Macklin, R., “Bioethics, Vulnerability, and Protection,” Bioethics 17, nos. 5–6 (2003): 472–486, at 475.Google Scholar
La Vertu, D. S. and Linares, A. M., “Ethical Principles of Biomedical Research on Human Subjects: Their Application and Limitations in Latin America and the Caribbean,” Bulletin of Pan American Health Organization 24, no. 4 (1990): 469–479.Google Scholar
See Luna, , supra 3, at 80.Google Scholar
ángeles-Llerenas, A. R. Wirtz, V. Francisco, C., and álvarez, L., “The Role and Responsibilities of Witnesses in the Informed Consent Process,” Developing World Bioethics 9, no. 1 (2009): 18–25, at 23.Google Scholar
Verástegui, E. L., “Consenting of the Vulnerable: The Informed Consent Procedure in Advanced Cancer Patients in Mexico,” BioMed Central 7, no. 13 (2006): 1–12, available at <http://www.biomedcentral.com/content/pdf/1472-6939-7-13.pdf> (last visited March 3, 2013).Google Scholar
See Angeles-Llerenas, Wirtz, , and Lara-Alvarez, , supra 21.Google Scholar
See Vertu, La and Linares, , supra 33, at 475–476.Google Scholar
See Takahashi, Ramos, Pinheiro-Neto, Miziara, , and de Oliveira, Ayer, supra 24, at 266; Freitas, C. B. D. and Hossne, W. S., “Pesquisa com seres humanos,” in Costa, S. I. F. Oselka, G. Garrafa, V., eds., Inicia áo á Bioética (Brazil, Conselho Federal de Medicina, 1998): at 193–204.Google Scholar
See Luna, , supra 3, at 135.Google Scholar
Pessini, L. de Paul de Barchifontaine, C., and Stepke, F. L., eds., Ibero-American Bioethics: History and Perspectives (New York: Springer, 2009).Google Scholar
See DeYoung, and Nelson, , supra 8, at web page 5.Google Scholar
Macklin, R., Double Standards in Medical Research in Developing Countries (Cambridge: Cambridge University Press, 2004): at 7.CrossRefGoogle Scholar
See Vertu, La and Linares, , supra 33.Google Scholar
Hurtado, M. Hill, K. Kaplan, H., and Lancaster, J., “The Epidemiology of Infectious Diseases among South American Indians: A Call for Ethical Research Guidelines,” Current Anthropology 42, no. 3 (2012): 425–432.Google Scholar
See Luna, , supra 3.Google Scholar
Kottow, M. H., “Vulnerability: What Kind of Principle Is It?” Medicine, Health Care and Philosophy 7, no. 3 (2005): 281–287; Solbakk, J. H., “Vulnerability: A Futile or Utile Principle in Health Care Ethics?” in Chadwick, R. ten Have, H. Meslin, E., eds., Health Care Ethics in an Era of Globalisation (London: Sage, 2011); see Garrafa, Solbakk, Vidal, , and Lorenzo, , supra 30, at 502.Google Scholar
See Garrafa, Solbakk, Vidal, , and Lorenzo, , supra 30.Google Scholar
Id., at 503.Google Scholar
See Luna, , supra 3, at 127.Google Scholar
See Hurst, , supra 23, at 199.Google Scholar
Carmack, H. J. Bates, B. R., and Harter, L. M., “Narrative Constructions of Health Care Issues and Policies: The Case of President Clinton's Apology-by-Proxy for the Tuskegee Syphilis Experiment,” Journal of Medical Humanities 29, no. 2 (2008): 89–109, at 92.Google Scholar
See Carmack, Bates, , and Harter, , supra 52, at 103.Google Scholar
Id., at 98.Google Scholar
Nie, J-B., “The United States Cover-Up of Japanese Wartime Medical Atrocities: Complicity Committed in the National Interest and Two Proposals for Contemporary Action,” American Journal of Bioethics 6, no. 3 (2006): W21–W33, at W21.Google Scholar
See Nie, , supra 55, at W28-W29.Google Scholar
See Nie, , supra 55, at W29.Google Scholar
Alberstein, M. Davidovitch, N. Lombardo, P., and Scott, C., “Saying “I'm Sorry”: The Role of Apology in Public Health,” Journal of Law, Medicine & Ethics 35, no. 4, supp. (2007): 132–134.Google Scholar
Davis, P., “On apologies,” Journal of Applied Philosophy 19, no. 2 (2002): 169–173; Souder, L., “A Rhetorical Analysis of Apologies for Scientific Misconduct: Do They Really Mean It?” Science and Engineering Ethics 16, no. 1 (2010): 175–184, at 177.CrossRefGoogle Scholar
See Alberstein, Davidovitch, Lombardo, , and Scott, , supra note 58, at 133.Google Scholar
See Carmack, Bates, , and Harter, , supra 52, at 97–98.Google Scholar
See Alberstein, Davidovitch, Lombardo, , and Scott, , supra 58, at 132.Google Scholar
Bennett, C., “Taking the Sincerity Out of Saying Sorry: Restorative Justice as Ritual,” Journal of Applied Philosophy 23, no. 2 (2006): 128–143; Duff, R. A., Punishment, Communication and Community (Oxford: Oxford University Press, 2001).Google Scholar
Id. (Duff), at 94–95; see Bennett, , supra 63, at 138.Google Scholar
See Bennett, , supra 63, at 140.Google Scholar
See Bennett, , supra 63.Google Scholar
Thompson, J., “An Apology Paradox,” The Philosophical Quarterly 50, no. 201 (2000): 470–475, at 473.Google Scholar
See Thompson, , supra 67, at 475.Google Scholar
See Nie, , supra 55.Google Scholar
Grady, C., “Ethics of International Research: What Does Responsiveness Mean?” Virtual Mentor, Ethics Journal of the American Medical Association 8, no. 4 (2006): 235–240.Google Scholar
See Carmack, Bates, , and Harter, , supra note 52, at 98.Google Scholar
Voo, T-C. Chin, J., and Campbell, A.V., “Multinational Research,” The Hastings Center Bioethics Briefing Book, at 108, available at <http://www.thehastingscenter.org/uploadedFiles/Publications/Briefing_Book/multinational%20research%20chapter.pdf> (last visited January 3, 2012).Google Scholar
Zegers-Hochschild, F., “Barriers to Conducting Clinical Research in Reproductive Medicine: Latin America,” Fertility and Sterility 96, no. 4 (2011): 802–804, at 803.CrossRefGoogle Scholar
Barboza, M. Minaya, G., and Fuentes, D., “Hacia una comisión nacional de ética de la investigación en salud en perú: Apuntes acerca de rutas y procesos en perspectiva comparada,” Revista Peruana de Medicina Experimental y Salud Publica 27, no. 4 (2010): 621–628.CrossRefGoogle Scholar
Lescano, A. R. Blazes, D. L. Montano, S. M. Moran, Z. Naquira, C. Ramirez, E. Lie, R. Martin, G. J. Lescano, A. G., and Zunt, J. R., “Research Ethics Training in Peru: A Case Study,” PLoS One 3, no. 9 (2008): E3274.Google Scholar
Silva, H. Sungar, E. Kleinstiver, S. J., and Rubin, R. H., “Opportunities and Challenges for Clinical and Cardiovascular Research in Latin America,” American Journal of Therapeutics 13, no. 4 (2006): 309–314, at 313.CrossRefGoogle Scholar
Reverby, S. M., “Listening to Narratives from the Tuskegee Syphilis Study,” The Lancet 377, no. 9778 (2011): 1646–1647, at 1647.Google Scholar